Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endobronchial Epstein-Barr Virus-Associated Smooth Muscle Tumor in Advanced HIV Infection: A Rare Case.

The American journal of case reports·2026
Same author

Circulating Biomarkers for Predicting Disease Progression in Idiopathic Pulmonary Fibrosis: Insights into Precision Medicine.

Lung·2026
Same author

Sharpening the Aim: A Needed Clarification of Diagnostic Yield in Bronchoscopy Research.

Chest·2026
Same author

Diagnostic yield: what is sufficient?

Current opinion in pulmonary medicine·2025
Same author

Risk-adapted venous thromboembolism prophylaxis in Asian patients admitted to medical intensive care unit: a prospective controlled trial.

Thrombosis journal·2025
Same author

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?

The Annals of thoracic surgery·2025

Related Experiment Video

Updated: Dec 15, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?

Pattraporn Tajarernmuang1,2, Linda Ofiara3, Stéphane Beaudoin3

  • 1Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Journal of Thoracic Disease
|July 10, 2020
PubMed
Summary
This summary is machine-generated.

Flexible bronchoscopy is crucial for obtaining lung cancer tissue samples for personalized treatments. Advanced techniques ensure sufficient tissue for mutation analysis and PD-L1 testing in advanced lung cancer patients.

Keywords:
Bronchoscopyimmunohistochemistry (IHC)lung cancermolecular testingprogrammed death-ligand 1 (PD-L1)

More Related Videos

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

1.1K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.2K

Related Experiment Videos

Last Updated: Dec 15, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

1.1K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.2K

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Diagnostics

Background:

  • Advanced lung cancer treatment is increasingly personalized, driven by molecular biology and immunity insights.
  • Accurate diagnosis and staging rely on small biopsy and cytology specimens, especially in advanced disease.
  • Flexible bronchoscopy is a key method for obtaining these diagnostic tissue samples.

Purpose of the Study:

  • To review evidence on flexible bronchoscopy techniques for acquiring lung cancer tissue.
  • To assess the role of these techniques in enabling mutation analysis and PD-L1 testing.

Main Methods:

  • Narrative review of existing literature.
  • Focus on conventional and advanced flexible bronchoscopy methods.
  • Evaluation of tissue acquisition for molecular and immunologic profiling.

Main Results:

  • Flexible bronchoscopy is vital for obtaining diagnostic specimens in advanced lung cancer.
  • Various techniques, both conventional and advanced, are employed.
  • Sufficient tissue acquisition is essential for subsequent molecular and PD-L1 testing.

Conclusions:

  • Flexible bronchoscopy plays a critical role in personalized lung cancer care.
  • Optimizing bronchoscopic techniques is key to successful mutation and PD-L1 analysis.
  • This ensures appropriate targeted therapy selection for advanced lung cancer patients.